Simbec-Orion Group was created in 2014 by the merger of Simbec Research, the specialist CRO in Early Stage Clinical Development and Orion Clinical, a specialist European Late Stage CRO to create an international, full service, boutique CRO.

We offer our clients:

  • A full spectrum of drug development services from first-in-human Phase I clinical studies through to pivotal Phase III studies and Phase IV post marketing studies.
  • Specialist expertise in oncology, rare and orphan diseases, respiratory, dermatology and infectious diseases & vaccines
  • In-depth experience of all drug types, dosage forms and delivery mechanisms.
  • Access to patient populations across Europe and North America.